| Reference | Name | Unity | Provider | Aplication | Clonality | Host | Reactivity | Price | Tech.Sheet |
|---|---|---|---|---|---|---|---|---|---|
| Ab00511-1.7 | Anti-Vaginolysin [9B4] | 200 ug | Absolute Antibody | ELISA; WB; Block | Other | Request Quotation | Request | ||
| Ab00510-1.7 | Anti-Vaginolysin [23A2] | 200 ug | Absolute Antibody | ELISA; WB; Block | Other | Request Quotation | Request | ||
| Ab03830-23.0 | Anti-MUC1-C/ECD [6A6] | 100 ug | Absolute Antibody | FC; ELISA; WB | Human | Request Quotation | Request | ||
| Ab03796-1.1 | Anti-APP [2F9] | 100 ug | Absolute Antibody | ELISA; blocking | Human, Mouse | Request Quotation | Request | ||
| Ab03807-11.0 | Anti-CTLA-4 [4.13.1] | 100 ug | Absolute Antibody | Human | Request Quotation | Request | |||
| Ab03793-23.0-BT | Anti-CD44v6 [BIWA4] | 1 mg | Absolute Antibody | in vivo; ELISA; therapeutic; SPR | Human | Request Quotation | Request | ||
| Ab03790-1.1-BT | Anti-HCV E1 [5D2] | 1 mg | Absolute Antibody | ELISA; Neutralizing; SPR | Hepatitis C virus | Request Quotation | Request | ||
| Ab03810-23.0 | Anti-VEGF-D [3A] | 100 ug | Absolute Antibody | SPR | Human | Request Quotation | Request | ||
| Ab03816-1.1-BT | Anti-Gn [Mab-2 (23B5-1)] | 1 mg | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Request Quotation | Request | ||
| Ab03836-21.0-BT | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [MAb4-5] | 500 ug | Absolute Antibody | Cristallography; Neutralizing; SPR; WB | Severe Fever and Thrombocytopenic Syndrome Virus | Request Quotation | Request | ||
| Ab03793-10.0-BT | Anti-CD44v6 [BIWA4] | 1 mg | Absolute Antibody | in vivo; ELISA; therapeutic; SPR | Human | Request Quotation | Request | ||
| Ab03819-10.0 | Anti-ODC1 [ODC1-2] | 100 ug | Absolute Antibody | WB; IHC; ELISA | Human | Request Quotation | Request | ||
| Ab03820-4.0 | Anti-SERPINA1 [SERPINA1-1] | 100 ug | Absolute Antibody | WB; IHC; ELISA; Inhibition | Human | Request Quotation | Request | ||
| Ab03826-23.0-BT | Anti-EGFR [EGFR-8] | 1 mg | Absolute Antibody | ELISA; WB; Inhibition | Human | Request Quotation | Request | ||
| Ab03803-23.0-BT | Anti-ICOS ligand [Clone 325] | 1 mg | Absolute Antibody | inhibit, Block, ELISA, FC | Human | Request Quotation | Request | ||
| Ab03845-10.0 | Anti-gp120 protein (CD4-binding domain) [559/64-D] | 100 ug | Absolute Antibody | ELISA; Neutralization; blocking | HIV-1 | Request Quotation | Request | ||
| Ab03812-1.1 | Anti-cytochrome C [R1D3] | 100 ug | Absolute Antibody | ICC | Mouse | Request Quotation | Request | ||
| Ab03829-23.0 | Anti-MET [7A2] | 100 ug | Absolute Antibody | SPR; inhibition; ELISA | Human | Request Quotation | Request | ||
| Ab03798-23.0 | Anti-PVRIG [334MXX] | 100 ug | Absolute Antibody | FACS | Human | Request Quotation | Request | ||
| Ab02491-10.3 | Anti-VEGFR2 [V2] | 200 ug | Absolute Antibody | ELISA; FC; functional assay | Human | Request Quotation | Request | ||
| Ab00136-10.7-BS | Anti-V5 epitope tag [SV5-P-K] | 1 mg | Absolute Antibody | ELISA; IF; IHC-Fr; IP; RIA; WB | Paramyxovirus Simian Virus 5 | Request Quotation | Request | ||
| Ab03830-10.0 | Anti-MUC1-C/ECD [6A6] | 100 ug | Absolute Antibody | FC; ELISA; WB | Human | Request Quotation | Request | ||
| Ab03827-1.1 | Anti-DLL4 [mh2F] | 100 ug | Absolute Antibody | ELISA; SPR; inhibition; in vivo | Human; Mouse | Request Quotation | Request | ||
| Ab03841-21.0 | Anti-Envelope protein E [6B6C-1] | 50 ug | Absolute Antibody | ELISA; WB | St. louis encephalitis virus (SLEV); Dengue virus | Request Quotation | Request | ||
| Ab03811-23.0-BT | Anti-MerTK [Ab2000] | 1 mg | Absolute Antibody | ELISA; Inhibition | Human | Request Quotation | Request | ||
| Ab03824-1.1 | Anti-4Ig-B7H3 [8H9] | 100 ug | Absolute Antibody | WB; therapeutic; in vivo; IHC; IP | Human | Request Quotation | Request | ||
| Ab03823-23.0-BT | Anti-Spike protein [3F4] | 1 mg | Absolute Antibody | ELISA | SARS Coronavirus 2 (SARS-Cov-2) | Request Quotation | Request | ||
| Ab03812-23.0-BT | Anti-cytochrome C [R1D3] | 1 mg | Absolute Antibody | ICC | Mouse | Request Quotation | Request | ||
| Ab03842-1.1-BT | Anti-Hendra and Nipah virus F [1F5] | 1 mg | Absolute Antibody | Functional assay; Neutralize | Hendra henipavirus (Hendra virus, HeV), Nipah he | Request Quotation | Request | ||
| Ab03837-1.1 | Anti-Integrin alpha 6 beta 1 [TS2/16] | 100 ug | Absolute Antibody | Cristallography; FC; IP; in vivo; in vitro | Human | Request Quotation | Request | ||
| Ab03037-10.3 | Anti-VEGFR2 [D3-D3] | 200 ug | Absolute Antibody | ELISA; IHC | Human | Request Quotation | Request | ||
| Ab03678-30.11 | Anti-Usutu virus envelop protein E [A9] | 50 ug | Absolute Antibody | ELISA; WB | Usutu virus (USUV) | Request Quotation | Request | ||
| Ab03809-30.11-BT | Anti-VEGF-D; AR74 [1A] | 500 ug | Absolute Antibody | ELISA; SPR | Human | Request Quotation | Request | ||
| Ab00136-6.4-BT | Anti-V5 epitope tag [SV5-P-K] | 1 mg | Absolute Antibody | ELISA; IF; IHC-Fr; IP; RIA; WB | Paramyxovirus Simian Virus 5 | Request Quotation | Request | ||
| Ab03799-10.0 | Anti-FZD7 [Fab-1219] | 100 ug | Absolute Antibody | WB | Human | Request Quotation | Request | ||
| Ab03796-23.0 | Anti-APP [2F9] | 100 ug | Absolute Antibody | ELISA; blocking | Human, Mouse | Request Quotation | Request | ||
| Ab03796-10.0 | Anti-APP [2F9] | 100 ug | Absolute Antibody | ELISA; blocking | Human, Mouse | Request Quotation | Request | ||
| Ab03815-1.1-BT | Anti-Gn [Mab-1 (23A8-1)] | 1 mg | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Request Quotation | Request | ||
| Ab03806-23.0 | Anti-C3 [C3-2] | 100 ug | Absolute Antibody | ELISA; WB; Inhibition; SPR | Human | Request Quotation | Request | ||
| Ab03818-23.0 | Anti-mammalian sTnI [6G1] | 100 ug | Absolute Antibody | WB; ELISA | Horse; Pig; Cattle; Deer; Sheep | Request Quotation | Request | ||
| Ab03798-1.1-BT | Anti-PVRIG [334MXX] | 1 mg | Absolute Antibody | FACS | Human | Request Quotation | Request | ||
| Ab01918-10.29-BS | Anti-VAX1 [RAB-T73] | 1 mg | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab03797-1.1-BT | Anti-HLA/EBNA1 [anti-HLA-A0201/EBNA1 antibody] | 1 mg | Absolute Antibody | SPR; IHC; FC | Epstein-Barr virus | Request Quotation | Request | ||
| Ab03816-23.0 | Anti-Gn [Mab-2 (23B5-1)] | 100 ug | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Request Quotation | Request | ||
| Ab03794-23.0-BT | Anti-CD44v6 [BIWA8] | 1 mg | Absolute Antibody | in vivo | Human | Request Quotation | Request | ||
| Ab03824-23.0 | Anti-4Ig-B7H3 [8H9] | 100 ug | Absolute Antibody | WB; therapeutic; in vivo; IHC; IP | Human | Request Quotation | Request | ||
| Ab03803-10.0 | Anti-ICOS ligand [Clone 325] | 100 ug | Absolute Antibody | inhibit, Block, ELISA, FC | Human | Request Quotation | Request | ||
| Ab03817-23.0-BT | Anti-Gn [Mab-3 (32A8-1)] | 1 mg | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Request Quotation | Request | ||
| Ab03833-10.0-BT | Anti-CD98 [8-34B] | 1 mg | Absolute Antibody | Inhibition; in vivo; IHC; FACS; SPR | Human | Request Quotation | Request | ||
| Ab03807-10.0 | Anti-CTLA-4 [4.13.1] | 100 ug | Absolute Antibody | Human | Request Quotation | Request |